Market Closed -
Nyse
04:00:02 2024-06-10 pm EDT
|
5-day change
|
1st Jan Change
|
348.2
USD
|
-0.33%
|
|
+2.59%
|
+16.27%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
78,602
|
92,084
|
100,882
|
92,522
|
113,776
|
132,635
|
-
|
-
|
Enterprise Value (EV)
1 |
84,408
|
102,290
|
110,335
|
102,451
|
121,655
|
139,898
|
137,107
|
134,053
|
P/E ratio
|
38.3
x
|
58.3
x
|
51.3
x
|
39.6
x
|
36.3
x
|
34
x
|
29.7
x
|
26.7
x
|
Yield
|
1.02%
|
0.96%
|
0.97%
|
1.16%
|
-
|
0.95%
|
1.04%
|
1.14%
|
Capitalization / Revenue
|
5.28
x
|
6.42
x
|
5.9
x
|
5.02
x
|
5.55
x
|
5.95
x
|
5.53
x
|
5.14
x
|
EV / Revenue
|
5.67
x
|
7.13
x
|
6.45
x
|
5.55
x
|
5.93
x
|
6.27
x
|
5.71
x
|
5.19
x
|
EV / EBITDA
|
20
x
|
26.6
x
|
23.2
x
|
21.5
x
|
22.7
x
|
23.1
x
|
20.4
x
|
18.3
x
|
EV / FCF
|
54.7
x
|
36.7
x
|
40.3
x
|
50.3
x
|
39.2
x
|
40.6
x
|
32.9
x
|
29.4
x
|
FCF Yield
|
1.83%
|
2.73%
|
2.48%
|
1.99%
|
2.55%
|
2.46%
|
3.04%
|
3.41%
|
Price to Book
|
6.14
x
|
7.04
x
|
6.79
x
|
5.56
x
|
6.11
x
|
6.26
x
|
5.51
x
|
4.79
x
|
Nbr of stocks (in thousands)
|
374,400
|
375,791
|
377,240
|
378,430
|
379,938
|
380,950
|
-
|
-
|
Reference price
2 |
209.9
|
245.0
|
267.4
|
244.5
|
299.5
|
348.2
|
348.2
|
348.2
|
Announcement Date
|
1/28/20
|
1/27/21
|
1/27/22
|
1/31/23
|
1/30/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
14,884
|
14,351
|
17,108
|
18,449
|
20,498
|
22,302
|
23,997
|
25,807
|
EBITDA
1 |
4,222
|
3,839
|
4,753
|
4,755
|
5,348
|
6,051
|
6,708
|
7,310
|
EBIT
1 |
3,908
|
3,499
|
4,382
|
4,384
|
4,955
|
5,612
|
6,266
|
6,851
|
Operating Margin
|
26.26%
|
24.38%
|
25.61%
|
23.76%
|
24.17%
|
25.16%
|
26.11%
|
26.55%
|
Earnings before Tax (EBT)
1 |
2,562
|
1,954
|
2,281
|
2,683
|
3,673
|
4,498
|
5,319
|
5,978
|
Net income
1 |
2,083
|
1,599
|
1,994
|
2,358
|
3,165
|
3,883
|
4,454
|
4,985
|
Net margin
|
13.99%
|
11.14%
|
11.66%
|
12.78%
|
15.44%
|
17.41%
|
18.56%
|
19.32%
|
EPS
2 |
5.480
|
4.200
|
5.210
|
6.170
|
8.250
|
10.24
|
11.74
|
13.05
|
Free Cash Flow
1 |
1,542
|
2,790
|
2,738
|
2,036
|
3,105
|
3,446
|
4,164
|
4,566
|
FCF margin
|
10.36%
|
19.44%
|
16%
|
11.04%
|
15.15%
|
15.45%
|
17.35%
|
17.69%
|
FCF Conversion (EBITDA)
|
36.52%
|
72.68%
|
57.61%
|
42.82%
|
58.06%
|
56.96%
|
62.08%
|
62.47%
|
FCF Conversion (Net income)
|
74.03%
|
174.48%
|
137.31%
|
86.34%
|
98.1%
|
88.76%
|
93.48%
|
91.6%
|
Dividend per Share
2 |
2.135
|
2.355
|
2.585
|
2.835
|
-
|
3.317
|
3.610
|
3.978
|
Announcement Date
|
1/28/20
|
1/27/21
|
1/27/22
|
1/31/23
|
1/30/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
4,701
|
4,275
|
4,493
|
4,479
|
5,202
|
4,778
|
4,996
|
4,909
|
5,815
|
5,243
|
5,405
|
5,344
|
6,320
|
5,636
|
5,808
|
EBITDA
1 |
1,378
|
1,026
|
1,156
|
1,092
|
1,481
|
1,102
|
1,314
|
1,247
|
1,685
|
1,253
|
1,428
|
1,431
|
1,940
|
1,440
|
1,602
|
EBIT
1 |
1,285
|
934
|
1,063
|
1,001
|
1,386
|
1,006
|
1,216
|
1,149
|
1,584
|
1,146
|
1,323
|
1,322
|
1,820
|
1,325
|
1,497
|
Operating Margin
|
27.33%
|
21.85%
|
23.66%
|
22.35%
|
26.64%
|
21.05%
|
24.34%
|
23.41%
|
27.24%
|
21.86%
|
24.48%
|
24.73%
|
28.8%
|
23.5%
|
25.77%
|
Earnings before Tax (EBT)
1 |
757
|
386
|
720
|
816
|
761
|
679
|
899
|
869
|
1,226
|
923
|
1,085
|
1,072
|
1,645
|
1,182
|
1,341
|
Net income
1 |
662
|
323
|
656
|
816
|
563
|
592
|
738
|
692
|
1,143
|
788
|
943.4
|
941.3
|
1,385
|
1,013
|
1,112
|
Net margin
|
14.08%
|
7.56%
|
14.6%
|
18.22%
|
10.82%
|
12.39%
|
14.77%
|
14.1%
|
19.66%
|
15.03%
|
17.45%
|
17.62%
|
21.92%
|
17.98%
|
19.15%
|
EPS
2 |
1.730
|
0.8400
|
1.720
|
2.140
|
1.470
|
1.540
|
1.930
|
1.800
|
2.980
|
2.050
|
2.447
|
2.440
|
3.584
|
2.555
|
2.873
|
Dividend per Share
2 |
0.6950
|
0.6950
|
0.6950
|
0.6950
|
0.7500
|
0.7500
|
0.7500
|
0.7500
|
-
|
-
|
0.7960
|
0.7944
|
0.8357
|
0.8437
|
0.8464
|
Announcement Date
|
1/27/22
|
4/28/22
|
7/26/22
|
10/31/22
|
1/31/23
|
5/1/23
|
8/3/23
|
11/2/23
|
1/30/24
|
4/30/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
5,806
|
10,206
|
9,453
|
9,929
|
7,879
|
7,262
|
4,471
|
1,418
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.375
x
|
2.659
x
|
1.989
x
|
2.088
x
|
1.473
x
|
1.2
x
|
0.6666
x
|
0.194
x
|
Free Cash Flow
1 |
1,542
|
2,790
|
2,738
|
2,036
|
3,105
|
3,446
|
4,164
|
4,566
|
ROE (net income / shareholders' equity)
|
25.6%
|
21.8%
|
24.8%
|
22.7%
|
23.1%
|
23%
|
22.1%
|
21.3%
|
ROA (Net income/ Total Assets)
|
10.9%
|
8.77%
|
10.1%
|
9.99%
|
10.6%
|
10.4%
|
11.4%
|
12%
|
Assets
1 |
19,044
|
18,240
|
19,791
|
23,611
|
29,877
|
37,444
|
39,111
|
41,671
|
Book Value Per Share
2 |
34.20
|
34.80
|
39.40
|
43.90
|
49.00
|
55.60
|
63.20
|
72.60
|
Cash Flow per Share
2 |
5.770
|
8.620
|
8.540
|
6.870
|
9.590
|
12.20
|
13.30
|
14.80
|
Capex
1 |
649
|
487
|
525
|
588
|
575
|
665
|
713
|
753
|
Capex / Sales
|
4.36%
|
3.39%
|
3.07%
|
3.19%
|
2.81%
|
2.98%
|
2.97%
|
2.92%
|
Announcement Date
|
1/28/20
|
1/27/21
|
1/27/22
|
1/31/23
|
1/30/24
|
-
|
-
|
-
|
Last Close Price
348.2
USD Average target price
373.1
USD Spread / Average Target +7.15% Consensus |
1st Jan change
|
Capi.
|
---|
| +16.27% | 133B | | -4.78% | 11.4B | | -4.86% | 8.3B | | +42.16% | 5.69B | | -20.87% | 4.78B | | +7.73% | 3.42B | | -19.39% | 2.48B | | -13.36% | 2.03B | | -16.39% | 1.86B | | -31.24% | 1.59B |
Medical Devices & Implants
|